NL-OMON44039已完成不适用
FARAH study Fecal trAnsplantation to Reduce therapy-refractory graft versus host disease in Allogeneic Hematopoietic stem cell transplantation - FARAH
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Male and female
- •- > 18 years of age
- •- allogeneic HSCT recipients
- •- non critically ill
- •- steroid- and mesenchymal stromal therapy resistant intestinal GvHD (biopsy proven)
排除标准
- •- unable to sign informed consent
研究者
相似试验
已完成
不适用
Healthy feces to treat intestinal disease in transplant patientsGraft versus host disease of the intestine (GvHD)Digestive SystemSteroid-refractory or steroid-dependent graft vs host disease in the intestine (GvHD)ISRCTN14530574Amsterdam UMC Department of Hematology15
招募中
3 期
Fecal transplantation to Eradicate Colonizing Emergent Superbugs2024-516393-29-00Assistance Publique Hopitaux De Paris299
已完成
不适用
FAME study: Fecal Administration for eradication of Multiresistant ESBL producing bacteria in carrierscarriage of multiresistent bacteriaESBL carriage10002252NL-OMON41318Academisch Medisch Centrum10
已完成
1 期
FMT for Multidrug Resistant Organism ReversalInfection With Multi-drug Resistant OrganismsNCT02312986Washington University School of Medicine1
Unknown
不适用
Fecal Transplant for MDRO DecolonizationMulti-antibiotic ResistanceNCT04181112University of British Columbia90